CEPI CEO pitches his 100-day vaccine development project amid hantavirus outbreak

Dr. Richard Hatchett was recently in Ottawa seeking support for the project. His trip’s timing—amid news of the spread of hantavirus on a cruise ship—was a coincidence, but has reinforced ‘that these kinds of threats are continually and unpredictably emerging,’ he says.
Dr. Richard Hatchett is the CEO of the Coalition for Epidemic Preparedness Innovations, which he joined in 2017 after leaving his role as acting director of the Biomedical Advanced Research and Development Authority, a U.S. federal agency focused on developing medical countermeasures to combat mass public health and medical emergencies.

The hantavirus outbreak, which has attracted global attention since it broke out last month, proves that countries should be investing in vaccine preparedness and global co-operation because the spread of viruses and outbreaks will continue, says Dr. Richard Hatchett, CEO of...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.


Already a Subscriber?

Get Innovation & Industry Newsletter

From investment to regulation, the policies, decisions and people working on industry and innovation. Tuesday.


By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

MORE News

RELATED STORIES